Mischel PS - Search Results

1

mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma.

Masui K, Harachi M, Ikegami S, Yang H, Onizuka H, Yong WH, Cloughesy TF, Muragaki Y, Kawamata T, Arai N, Komori T, Cavenee WK, Mischel PS, Shibata N. Masui K, et al. Among authors: mischel ps. J Biol Chem. 2019 Dec 20;294(51):19740-19751. doi: 10.1074/jbc.RA119.011519. Epub 2019 Nov 11. J Biol Chem. 2019. PMID: 31712311 Free PMC article.

2

The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA.

Mischel PS, Smith SG, Vining ER, Valletta JS, Mobley WC, Reichardt LF. Mischel PS, et al. J Biol Chem. 2001 Apr 6;276(14):11294-301. doi: 10.1074/jbc.M005132200. Epub 2001 Jan 9. J Biol Chem. 2001. PMID: 11150291 Free PMC article.

3

Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS. Choe G, et al. Among authors: mischel ps. Clin Cancer Res. 2002 Sep;8(9):2894-901. Clin Cancer Res. 2002. PMID: 12231534

4

Targeted molecular therapy of GBM.

Mischel PS, Cloughesy TF. Mischel PS, et al. Brain Pathol. 2003 Jan;13(1):52-61. doi: 10.1111/j.1750-3639.2003.tb00006.x. Brain Pathol. 2003. PMID: 12580545 Free PMC article. Review.

5

Identification of molecular subtypes of glioblastoma by gene expression profiling.

Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF. Mischel PS, et al. Oncogene. 2003 Apr 17;22(15):2361-73. doi: 10.1038/sj.onc.1206344. Oncogene. 2003. PMID: 12700671

6

Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.

Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS. Choe G, et al. Among authors: mischel ps. Cancer Res. 2003 Jun 1;63(11):2742-6. Cancer Res. 2003. PMID: 12782577

7

Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.

Mischel PS, Nelson SF, Cloughesy TF. Mischel PS, et al. Cancer Biol Ther. 2003 May-Jun;2(3):242-7. doi: 10.4161/cbt.2.3.369. Cancer Biol Ther. 2003. PMID: 12878856 Review.

8

Gene expression profiling identifies molecular subtypes of gliomas.

Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Shai R, et al. Among authors: mischel ps. Oncogene. 2003 Jul 31;22(31):4918-23. doi: 10.1038/sj.onc.1206753. Oncogene. 2003. PMID: 12894235

9

Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.

Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. Lu KV, et al. Among authors: mischel ps. Lab Invest. 2004 Jan;84(1):8-20. doi: 10.1038/sj.labinvest.3700003. Lab Invest. 2004. PMID: 14631378

10

p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition.

Wang Y, Zhu S, Cloughesy TF, Liau LM, Mischel PS. Wang Y, et al. Among authors: mischel ps. Oncogene. 2004 Feb 12;23(6):1283-90. doi: 10.1038/sj.onc.1207244. Oncogene. 2004. PMID: 14961077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters